52 results
D
RNXT
RenovoRx Inc
22 Apr 24
$15.00 mm in equity / options / securities to be acquired, sold $11.14 mm, 172 investors
11:26am
that is the subject of this Form D, States cannot
routinely require offering materials under this undertaking or otherwise and can require offering materials only
8-K
EX-10.1
RNXT
RenovoRx Inc
15 Apr 24
Unregistered Sales of Equity Securities
9:00am
, including any scientific, technical, trade or business secrets of the Company and any scientific, technical, trade or business materials that are treated
D
RNXT
RenovoRx Inc
9 Feb 24
Exempt offering of security
4:15pm
cannot
routinely require offering materials under this undertaking or otherwise and can require offering materials only to the
extent NSMIA permits them to do so under NSMIA's preservation of their anti-fraud authority.
8-K
EX-10.4
7fdbea 6f5t9h5ljt7
29 Jan 24
RenovoRx Closes $6.1 Million Private Placement
9:06am
8-K
EX-10.1
4l79xi udhh
29 Jan 24
RenovoRx Closes $6.1 Million Private Placement
9:06am
PRE 14A
cew0 9v5buj8uqlnjmo
17 Nov 23
Preliminary proxy
5:30pm
8-K
d88o 4muxw31jd
8 Sep 23
Amendments to Articles of Incorporation or Bylaws
7:41pm
8-K
EX-10.1
i2k 03vpdrmcvbh
3 Apr 23
RenovoRx, Inc. Announces $5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:45pm
8-K
EX-10.2
jg55 t3qv
3 Apr 23
RenovoRx, Inc. Announces $5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:45pm
424B5
z293kt3n3189
3 Apr 23
Prospectus supplement for primary offering
9:00am
424B3
cxmlst59g2yg ad
22 Nov 22
Prospectus supplement
5:20pm